Randomized Evaluation of Intralesion vs Intracoronary Abciximab and Aspiration Thrombectomy in Patients with STEMI: The COCTAIL II trial

Conclusions In patients with STEMI and high thrombotic burden, neither IL vs. IC abciximab nor AT vs. no aspiration reduced post procedure intra-stent athero-thrombotic burden in patients with STEMI undergoing primary PCI. However, IL abciximab improved indices of angiographic and myocardial reperfusion compared to IC abciximab, benefits not apparent with AT.
Source: American Heart Journal - Category: Cardiology Source Type: research